Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Switching to Ziprasidone in Schizophrenia and Schizoaffective Disorder
NCT00458211Phase 4Completed
- Sponsor
- Bronx Psychiatric Center
- Start
- May 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ziprasidone in schizophrenia, schizoaffective disorder, sponsored by Bronx Psychiatric Center. Started May 2005; status: completed.
02
Drugs
ziprasidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00458211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458211.